Showing results (381-390 of 671) with videos related to

Sort By:
Pageof 68
International Journal of Oncology|July 16, 2002
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populationsJ K Field, C Brambilla, N Caporaso, et al.
The Journal of Clinical Investigation|April 26, 2014
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonismYanan Yang, Young-Ho Ahn, Yulong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Radiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancerOliver Delgado, Kimberly G Batten, James A Richardson, et al.
BJC Reports|November 8, 2024
New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasisIsha Khanduri, Harufumi Maki, Anuj Verma, et al.
Cancer Research|June 28, 2014
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targetsAyumu Taguchi, Allen D Taylor, Jaime Rodriguez, et al.
Plos One|August 14, 2008
A Semantic Web management model for integrative biomedical informaticsHelena F Deus, Romesh Stanislaus, Diogo F Veiga, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015
KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.
The American Journal of Pathology|June 19, 2016
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical ActivityMarina Cardó-Vila, Serena Marchiò, Masanori Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.
Pageof 68